2,509
Views
12
CrossRef citations to date
0
Altmetric
Commentary

A novel role for ketoconazole in hepatocellular carcinoma treatment: linking PTGS2 to mitophagy machinery

, , , &
Pages 733-734 | Received 30 Oct 2018, Accepted 11 Dec 2018, Published online: 22 Jan 2019

Figures & data

Figure 1. Schematic illustrating the mechanism by which ketoconazole exacerbates mitophagy to induce apoptosis in HCC. Ketoconazole-induced downregulation of PTGS2 activates PINK1-PRKN signaling, which initiates and exacerbates mitophagy of healthy mitochondria. The induction of excessive mitophagy leads to mitochondrial dysfunction and consequent apoptosis, resulting in growth suppression of HCC. HCC, hepatocellular carcinoma.

Figure 1. Schematic illustrating the mechanism by which ketoconazole exacerbates mitophagy to induce apoptosis in HCC. Ketoconazole-induced downregulation of PTGS2 activates PINK1-PRKN signaling, which initiates and exacerbates mitophagy of healthy mitochondria. The induction of excessive mitophagy leads to mitochondrial dysfunction and consequent apoptosis, resulting in growth suppression of HCC. HCC, hepatocellular carcinoma.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.